KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Consolidated Net Income (2016 - 2025)

Novartis Ag's Consolidated Net Income history spans 15 years, with the latest figure at $4.5 billion for Q2 2025.

  • On a quarterly basis, Consolidated Net Income rose 17.96% to $4.5 billion in Q2 2025 year-over-year; TTM through Mar 2026 was $4.5 billion, a 58.09% decrease, with the full-year FY2025 number at $14.0 billion, up 16.99% from a year prior.
  • Consolidated Net Income hit $4.5 billion in Q2 2025 for Novartis Ag, down from $7.0 billion in the prior quarter.
  • Over the last five years, Consolidated Net Income for NVS hit a ceiling of $7.0 billion in Q4 2024 and a floor of $46.0 million in Q2 2023.
  • Historically, Consolidated Net Income has averaged $2.3 billion across 5 years, with a median of $595.0 million in 2022.
  • Biggest five-year swings in Consolidated Net Income: crashed 99.1% in 2023 and later surged 8250.0% in 2024.
  • Tracing NVS's Consolidated Net Income over 5 years: stood at $6.0 billion in 2021, then plummeted by 97.46% to $151.0 million in 2022, then increased by 25.83% to $190.0 million in 2023, then skyrocketed by 3568.42% to $7.0 billion in 2024, then tumbled by 34.99% to $4.5 billion in 2025.
  • Business Quant data shows Consolidated Net Income for NVS at $4.5 billion in Q2 2025, $7.0 billion in Q4 2024, and $3.8 billion in Q2 2024.